High leucovorin doses during high-dose methotrexate treatment may reduce the cure rate in childhood acute lymphoblastic leukemia.

Tor Skärby, Harald Anderson, Jesper Heldrup, J A Kanerva, H Seidel, K Schmiegelow

Research output: Contribution to journal › Article › peer-review

Subject classification (UKÄ)

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{02911e9d277a487e94259f158fe81a07,

title = "High leucovorin doses during high-dose methotrexate treatment may reduce the cure rate in childhood acute lymphoblastic leukemia.",

author = "Tor Sk{\"a}rby and Harald Anderson and Jesper Heldrup and Kanerva, {J A} and H Seidel and K Schmiegelow",

year = "2006",

doi = "10.1038/sj.leu.2404404",

language = "English",

volume = "20",

pages = "1955--1962",

journal = "Leukemia",

issn = "1476-5551",

publisher = "Nature Publishing Group",

number = "11",

}

TY - JOUR

T1 - High leucovorin doses during high-dose methotrexate treatment may reduce the cure rate in childhood acute lymphoblastic leukemia.

AU - Skärby, Tor

AU - Anderson, Harald

AU - Heldrup, Jesper

AU - Kanerva, J A

AU - Seidel, H

AU - Schmiegelow, K

PY - 2006

Y1 - 2006

U2 - 10.1038/sj.leu.2404404

DO - 10.1038/sj.leu.2404404

M3 - Article

C2 - 16990760

SN - 1476-5551

VL - 20

SP - 1955

EP - 1962

JO - Leukemia

JF - Leukemia

IS - 11

ER -